nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—AKR1B1—epithelium—gallbladder cancer	0.023	0.108	CbGeAlD
Sulindac—AKR1B1—pancreas—gallbladder cancer	0.0205	0.0962	CbGeAlD
Sulindac—MAPK3—epithelium—gallbladder cancer	0.0166	0.0783	CbGeAlD
Sulindac—PPARD—pancreas—gallbladder cancer	0.0161	0.0757	CbGeAlD
Sulindac—ALB—gall bladder—gallbladder cancer	0.0153	0.0722	CbGeAlD
Sulindac—MAPK3—pancreas—gallbladder cancer	0.0148	0.0697	CbGeAlD
Sulindac—AKR1B1—liver—gallbladder cancer	0.013	0.0612	CbGeAlD
Sulindac—PPARD—liver—gallbladder cancer	0.0102	0.0481	CbGeAlD
Sulindac—AKR1B1—lymph node—gallbladder cancer	0.00998	0.0469	CbGeAlD
Sulindac—MAPK3—liver—gallbladder cancer	0.00943	0.0444	CbGeAlD
Sulindac—PTGS2—gall bladder—gallbladder cancer	0.00836	0.0393	CbGeAlD
Sulindac—PPARD—lymph node—gallbladder cancer	0.00785	0.0369	CbGeAlD
Sulindac—MAPK3—lymph node—gallbladder cancer	0.00723	0.034	CbGeAlD
Sulindac—CYP1A1—epithelium—gallbladder cancer	0.00515	0.0242	CbGeAlD
Sulindac—PTGS1—epithelium—gallbladder cancer	0.00452	0.0213	CbGeAlD
Sulindac—ALB—liver—gallbladder cancer	0.0045	0.0212	CbGeAlD
Sulindac—PTGS2—epithelium—gallbladder cancer	0.00432	0.0203	CbGeAlD
Sulindac—PTGS2—pancreas—gallbladder cancer	0.00385	0.0181	CbGeAlD
Sulindac—ALB—lymph node—gallbladder cancer	0.00345	0.0162	CbGeAlD
Sulindac—CYP1A2—liver—gallbladder cancer	0.00296	0.0139	CbGeAlD
Sulindac—CYP1A1—liver—gallbladder cancer	0.00292	0.0137	CbGeAlD
Sulindac—PTGS2—liver—gallbladder cancer	0.00245	0.0115	CbGeAlD
Sulindac—CYP1A1—lymph node—gallbladder cancer	0.00224	0.0105	CbGeAlD
Sulindac—PTGS1—lymph node—gallbladder cancer	0.00197	0.00925	CbGeAlD
Sulindac—PTGS2—lymph node—gallbladder cancer	0.00188	0.00884	CbGeAlD
Sulindac—MAPK3—Oncostatin M Signaling Pathway—HRAS—gallbladder cancer	0.00137	0.00174	CbGpPWpGaD
Sulindac—MAPK3—mTOR signaling pathway—HRAS—gallbladder cancer	0.00135	0.00171	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling in naïve CD8+ T cells—HRAS—gallbladder cancer	0.00135	0.00171	CbGpPWpGaD
Sulindac—MAPK3—TSH signaling pathway—HRAS—gallbladder cancer	0.00135	0.00171	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways in Glioblastoma—KRAS—gallbladder cancer	0.00134	0.0017	CbGpPWpGaD
Sulindac—PTGS2—Aryl Hydrocarbon Receptor—EGFR—gallbladder cancer	0.00133	0.0017	CbGpPWpGaD
Sulindac—MAPK3—Rac1/Pak1/p38/MMP-2 pathway—HRAS—gallbladder cancer	0.00133	0.00169	CbGpPWpGaD
Sulindac—MAPK3—BCR signaling pathway—HRAS—gallbladder cancer	0.00133	0.00169	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—ERBB2—gallbladder cancer	0.00132	0.00168	CbGpPWpGaD
Sulindac—MAPK3—NCAM signaling for neurite out-growth—HRAS—gallbladder cancer	0.00132	0.00167	CbGpPWpGaD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—gallbladder cancer	0.0013	0.00165	CbGpPWpGaD
Sulindac—MAPK3—IRS-mediated signalling—KRAS—gallbladder cancer	0.0013	0.00165	CbGpPWpGaD
Sulindac—MAPK3—CDC42 signaling events—HRAS—gallbladder cancer	0.00129	0.00164	CbGpPWpGaD
Sulindac—MAPK3—ErbB1 downstream signaling—NRAS—gallbladder cancer	0.00127	0.00162	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—ERBB2—gallbladder cancer	0.00126	0.00161	CbGpPWpGaD
Sulindac—MAPK3—IRS-related events—KRAS—gallbladder cancer	0.00126	0.0016	CbGpPWpGaD
Sulindac—PTGS2—Aryl Hydrocarbon Receptor—KRAS—gallbladder cancer	0.00126	0.0016	CbGpPWpGaD
Sulindac—MAPK3—VEGFA-VEGFR2 Pathway—NRAS—gallbladder cancer	0.00125	0.00159	CbGpPWpGaD
Sulindac—MAPK3—IRS-related events triggered by IGF1R—KRAS—gallbladder cancer	0.00125	0.00159	CbGpPWpGaD
Sulindac—MAPK3—L1CAM interactions—EGFR—gallbladder cancer	0.00125	0.00158	CbGpPWpGaD
Sulindac—MAPK3—Signaling by Interleukins—NRAS—gallbladder cancer	0.00124	0.00158	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—ERBB2—gallbladder cancer	0.00124	0.00158	CbGpPWpGaD
Sulindac—PTGS2—C-MYB transcription factor network—BCL2—gallbladder cancer	0.00122	0.00155	CbGpPWpGaD
Sulindac—MAPK3—Alzheimers Disease—TP53—gallbladder cancer	0.00122	0.00155	CbGpPWpGaD
Sulindac—MAPK3—Leptin signaling pathway—HRAS—gallbladder cancer	0.00122	0.00155	CbGpPWpGaD
Sulindac—MAPK3—IGF1R signaling cascade—KRAS—gallbladder cancer	0.00122	0.00155	CbGpPWpGaD
Sulindac—MAPK3—TNF alpha Signaling Pathway—KRAS—gallbladder cancer	0.00122	0.00155	CbGpPWpGaD
Sulindac—MAPK3—Insulin receptor signalling cascade—KRAS—gallbladder cancer	0.00122	0.00155	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—ERBB3—gallbladder cancer	0.0012	0.00152	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—ERBB2—gallbladder cancer	0.00119	0.00151	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways in Glioblastoma—TP53—gallbladder cancer	0.00119	0.00151	CbGpPWpGaD
Sulindac—MAPK3—Glucocorticoid receptor regulatory network—TP53—gallbladder cancer	0.00119	0.00151	CbGpPWpGaD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—gallbladder cancer	0.00118	0.0015	CbGpPWpGaD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—gallbladder cancer	0.00118	0.0015	CbGpPWpGaD
Sulindac—MAPK3—Signaling by VEGF—NRAS—gallbladder cancer	0.00118	0.0015	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—ERBB2—gallbladder cancer	0.00118	0.0015	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—ERBB2—gallbladder cancer	0.00118	0.00149	CbGpPWpGaD
Sulindac—MAPK3—Signaling by Insulin receptor—NRAS—gallbladder cancer	0.00118	0.00149	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—ERBB2—gallbladder cancer	0.00117	0.00149	CbGpPWpGaD
Sulindac—MAPK3—ErbB1 downstream signaling—EGFR—gallbladder cancer	0.00116	0.00147	CbGpPWpGaD
Sulindac—MAPK3—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HRAS—gallbladder cancer	0.00116	0.00147	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways in Glioblastoma—HRAS—gallbladder cancer	0.00113	0.00144	CbGpPWpGaD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—gallbladder cancer	0.00112	0.00142	CbGpPWpGaD
Sulindac—MAPK3—PDGFR-beta signaling pathway—NRAS—gallbladder cancer	0.00111	0.00141	CbGpPWpGaD
Sulindac—MAPK3—IRS-mediated signalling—HRAS—gallbladder cancer	0.0011	0.0014	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—ERBB2—gallbladder cancer	0.0011	0.0014	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—ERBB2—gallbladder cancer	0.0011	0.0014	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—ERBB2—gallbladder cancer	0.0011	0.0014	CbGpPWpGaD
Sulindac—MAPK3—ErbB1 downstream signaling—KRAS—gallbladder cancer	0.0011	0.00139	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—ERBB2—gallbladder cancer	0.00109	0.00139	CbGpPWpGaD
Sulindac—MAPK3—Apoptosis Modulation and Signaling—TP53—gallbladder cancer	0.00109	0.00139	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—ERBB2—gallbladder cancer	0.00108	0.00137	CbGpPWpGaD
Sulindac—MAPK3—VEGFA-VEGFR2 Pathway—KRAS—gallbladder cancer	0.00108	0.00137	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—ERBB2—gallbladder cancer	0.00108	0.00137	CbGpPWpGaD
Sulindac—MAPK3—IRS-related events—HRAS—gallbladder cancer	0.00107	0.00136	CbGpPWpGaD
Sulindac—PTGS2—Aryl Hydrocarbon Receptor—HRAS—gallbladder cancer	0.00107	0.00136	CbGpPWpGaD
Sulindac—MAPK3—Signaling by Interleukins—KRAS—gallbladder cancer	0.00107	0.00136	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	0.00107	0.00136	CbGpPWpGaD
Sulindac—MAPK3—IRS-related events triggered by IGF1R—HRAS—gallbladder cancer	0.00106	0.00135	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—EGFR—gallbladder cancer	0.00106	0.00134	CbGpPWpGaD
Sulindac—MAPK3—TCR Signaling Pathway—HRAS—gallbladder cancer	0.00105	0.00134	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	0.00104	0.00132	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—ERBB4—gallbladder cancer	0.00104	0.00132	CbGpPWpGaD
Sulindac—MAPK3—Insulin receptor signalling cascade—HRAS—gallbladder cancer	0.00104	0.00131	CbGpPWpGaD
Sulindac—MAPK3—TNF alpha Signaling Pathway—HRAS—gallbladder cancer	0.00104	0.00131	CbGpPWpGaD
Sulindac—MAPK3—IGF1R signaling cascade—HRAS—gallbladder cancer	0.00104	0.00131	CbGpPWpGaD
Sulindac—MAPK3—Signaling by VEGF—KRAS—gallbladder cancer	0.00102	0.00129	CbGpPWpGaD
Sulindac—MAPK3—Signaling by Insulin receptor—KRAS—gallbladder cancer	0.00101	0.00128	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—NRAS—gallbladder cancer	0.00101	0.00128	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—ERBB2—gallbladder cancer	0.000976	0.00124	CbGpPWpGaD
Sulindac—MAPK3—Immune System—KEAP1—gallbladder cancer	0.000968	0.00123	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—NRAS—gallbladder cancer	0.000962	0.00122	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Actin Cytoskeleton—NRAS—gallbladder cancer	0.000962	0.00122	CbGpPWpGaD
Sulindac—MAPK3—PDGFR-beta signaling pathway—KRAS—gallbladder cancer	0.000953	0.00121	CbGpPWpGaD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—gallbladder cancer	0.000951	0.00121	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—NRAS—gallbladder cancer	0.000947	0.0012	CbGpPWpGaD
Sulindac—MAPK3—ErbB1 downstream signaling—HRAS—gallbladder cancer	0.000931	0.00118	CbGpPWpGaD
Sulindac—MAPK3—VEGFA-VEGFR2 Pathway—HRAS—gallbladder cancer	0.000917	0.00116	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—EGFR—gallbladder cancer	0.000916	0.00116	CbGpPWpGaD
Sulindac—MAPK3—Signaling by Interleukins—HRAS—gallbladder cancer	0.00091	0.00116	CbGpPWpGaD
Sulindac—PTGS2—C-MYB transcription factor network—NRAS—gallbladder cancer	0.000905	0.00115	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—NRAS—gallbladder cancer	0.000904	0.00115	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—NRAS—gallbladder cancer	0.0009	0.00114	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—ERBB3—gallbladder cancer	0.000896	0.00114	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—NRAS—gallbladder cancer	0.000895	0.00114	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—NRAS—gallbladder cancer	0.000891	0.00113	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—TP53—gallbladder cancer	0.000887	0.00113	CbGpPWpGaD
Sulindac—MAPK3—Oxidative Stress Induced Senescence—TP53—gallbladder cancer	0.000881	0.00112	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Actin Cytoskeleton—EGFR—gallbladder cancer	0.000876	0.00111	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—EGFR—gallbladder cancer	0.000876	0.00111	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—NRAS—gallbladder cancer	0.000874	0.00111	CbGpPWpGaD
Sulindac—MAPK3—Signaling by VEGF—HRAS—gallbladder cancer	0.000866	0.0011	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—KRAS—gallbladder cancer	0.000865	0.0011	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—EGFR—gallbladder cancer	0.000863	0.0011	CbGpPWpGaD
Sulindac—MAPK3—Signaling by Insulin receptor—HRAS—gallbladder cancer	0.00086	0.00109	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—NRAS—gallbladder cancer	0.000838	0.00106	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—NRAS—gallbladder cancer	0.000838	0.00106	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—NRAS—gallbladder cancer	0.000838	0.00106	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—NRAS—gallbladder cancer	0.000831	0.00106	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—gallbladder cancer	0.000829	0.00105	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Actin Cytoskeleton—KRAS—gallbladder cancer	0.000828	0.00105	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—KRAS—gallbladder cancer	0.000828	0.00105	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—EGFR—gallbladder cancer	0.000824	0.00105	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—NRAS—gallbladder cancer	0.000823	0.00105	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—EGFR—gallbladder cancer	0.00082	0.00104	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—NRAS—gallbladder cancer	0.00082	0.00104	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—EGFR—gallbladder cancer	0.000816	0.00104	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—KRAS—gallbladder cancer	0.000815	0.00103	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—EGFR—gallbladder cancer	0.000812	0.00103	CbGpPWpGaD
Sulindac—MAPK3—PDGFR-beta signaling pathway—HRAS—gallbladder cancer	0.00081	0.00103	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—EGFR—gallbladder cancer	0.000796	0.00101	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—ERBB4—gallbladder cancer	0.00079	0.001	CbGpPWpGaD
Sulindac—PTGS2—C-MYB transcription factor network—KRAS—gallbladder cancer	0.000779	0.000989	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—KRAS—gallbladder cancer	0.000778	0.000988	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—KRAS—gallbladder cancer	0.000774	0.000984	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—KRAS—gallbladder cancer	0.000771	0.000979	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—KRAS—gallbladder cancer	0.000767	0.000974	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—EGFR—gallbladder cancer	0.000764	0.00097	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—EGFR—gallbladder cancer	0.000764	0.00097	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—EGFR—gallbladder cancer	0.000764	0.00097	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—EGFR—gallbladder cancer	0.000757	0.000961	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—gallbladder cancer	0.000755	0.000959	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—gallbladder cancer	0.000755	0.000959	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—KRAS—gallbladder cancer	0.000752	0.000955	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—ERBB2—gallbladder cancer	0.000751	0.000953	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—EGFR—gallbladder cancer	0.00075	0.000953	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—EGFR—gallbladder cancer	0.000747	0.000949	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—NRAS—gallbladder cancer	0.000742	0.000943	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—HRAS—gallbladder cancer	0.000736	0.000934	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—NRAS—gallbladder cancer	0.000723	0.000919	CbGpPWpGaD
Sulindac—MAPK3—BDNF signaling pathway—HRAS—gallbladder cancer	0.000723	0.000919	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—KRAS—gallbladder cancer	0.000721	0.000916	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—KRAS—gallbladder cancer	0.000721	0.000916	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—KRAS—gallbladder cancer	0.000721	0.000916	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	0.000719	0.000913	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—gallbladder cancer	0.000717	0.000911	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—KRAS—gallbladder cancer	0.000715	0.000908	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—gallbladder cancer	0.000714	0.000906	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—KRAS—gallbladder cancer	0.000709	0.0009	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—KRAS—gallbladder cancer	0.000706	0.000896	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—HRAS—gallbladder cancer	0.000704	0.000894	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—HRAS—gallbladder cancer	0.000693	0.00088	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—ERBB3—gallbladder cancer	0.000683	0.000867	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—ERBB2—gallbladder cancer	0.000679	0.000863	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—TP53—gallbladder cancer	0.000679	0.000863	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	0.000679	0.000862	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—EGFR—gallbladder cancer	0.000676	0.000859	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—TP53—gallbladder cancer	0.000669	0.000849	CbGpPWpGaD
Sulindac—MAPK3—Insulin Signaling—HRAS—gallbladder cancer	0.000665	0.000844	CbGpPWpGaD
Sulindac—PTGS2—C-MYB transcription factor network—HRAS—gallbladder cancer	0.000662	0.000841	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—HRAS—gallbladder cancer	0.000662	0.00084	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—EGFR—gallbladder cancer	0.000659	0.000837	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—HRAS—gallbladder cancer	0.000658	0.000836	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—HRAS—gallbladder cancer	0.000655	0.000832	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—gallbladder cancer	0.000654	0.00083	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—HRAS—gallbladder cancer	0.000652	0.000828	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—KRAS—gallbladder cancer	0.000639	0.000812	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	0.000635	0.000806	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—EGFR—gallbladder cancer	0.000628	0.000798	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—KRAS—gallbladder cancer	0.000623	0.000791	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—gallbladder cancer	0.000617	0.000784	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	0.000617	0.000783	CbGpPWpGaD
Sulindac—MAPK3—Cellular Senescence—TP53—gallbladder cancer	0.000616	0.000783	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—HRAS—gallbladder cancer	0.000613	0.000779	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—HRAS—gallbladder cancer	0.000613	0.000779	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—HRAS—gallbladder cancer	0.000613	0.000779	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—HRAS—gallbladder cancer	0.000608	0.000772	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—gallbladder cancer	0.000606	0.00077	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	0.000603	0.000766	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—HRAS—gallbladder cancer	0.000602	0.000765	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—HRAS—gallbladder cancer	0.0006	0.000762	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—NRAS—gallbladder cancer	0.000581	0.000738	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—NRAS—gallbladder cancer	0.000571	0.000725	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—ERBB2—gallbladder cancer	0.000562	0.000713	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—HRAS—gallbladder cancer	0.000543	0.00069	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—HRAS—gallbladder cancer	0.000529	0.000672	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—TP53—gallbladder cancer	0.000527	0.00067	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—gallbladder cancer	0.000525	0.000667	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—EGFR—gallbladder cancer	0.00052	0.000661	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—NRAS—gallbladder cancer	0.000517	0.000656	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—KRAS—gallbladder cancer	0.0005	0.000635	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—KRAS—gallbladder cancer	0.000491	0.000624	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—ERBB2—gallbladder cancer	0.000485	0.000616	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—EGFR—gallbladder cancer	0.000471	0.000598	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—TP53—gallbladder cancer	0.000466	0.000591	CbGpPWpGaD
Sulindac—MAPK3—Immune System—ERBB4—gallbladder cancer	0.00046	0.000584	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—KRAS—gallbladder cancer	0.000445	0.000565	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—BCL2—gallbladder cancer	0.000441	0.00056	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—ERBB2—gallbladder cancer	0.000428	0.000544	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—NRAS—gallbladder cancer	0.000427	0.000543	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	0.000427	0.000543	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—HRAS—gallbladder cancer	0.000425	0.00054	CbGpPWpGaD
Sulindac—MAPK3—Disease—ERBB4—gallbladder cancer	0.000425	0.000539	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—HRAS—gallbladder cancer	0.000418	0.000531	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	0.000404	0.000513	CbGpPWpGaD
Sulindac—MAPK3—Immune System—ERBB3—gallbladder cancer	0.000398	0.000505	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—EGFR—gallbladder cancer	0.000389	0.000495	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—HRAS—gallbladder cancer	0.000378	0.00048	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—NRAS—gallbladder cancer	0.000369	0.000468	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—KRAS—gallbladder cancer	0.000368	0.000467	CbGpPWpGaD
Sulindac—MAPK3—Disease—ERBB3—gallbladder cancer	0.000367	0.000466	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—NRAS—gallbladder cancer	0.000362	0.000459	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	0.000359	0.000456	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—EGFR—gallbladder cancer	0.000336	0.000427	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TP53—gallbladder cancer	0.000327	0.000415	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—NRAS—gallbladder cancer	0.000326	0.000414	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—KRAS—gallbladder cancer	0.000317	0.000403	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—HRAS—gallbladder cancer	0.000313	0.000397	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—KRAS—gallbladder cancer	0.000311	0.000395	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—ERBB4—gallbladder cancer	0.000297	0.000378	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—EGFR—gallbladder cancer	0.000297	0.000377	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—KRAS—gallbladder cancer	0.00028	0.000356	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—TP53—gallbladder cancer	0.000277	0.000351	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—HRAS—gallbladder cancer	0.00027	0.000343	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—HRAS—gallbladder cancer	0.000265	0.000336	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—TP53—gallbladder cancer	0.000261	0.000332	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—ERBB3—gallbladder cancer	0.000257	0.000327	CbGpPWpGaD
Sulindac—MAPK3—Immune System—BCL2—gallbladder cancer	0.000257	0.000326	CbGpPWpGaD
Sulindac—PTGS2—Disease—ERBB4—gallbladder cancer	0.000253	0.000321	CbGpPWpGaD
Sulindac—MAPK3—Immune System—ERBB2—gallbladder cancer	0.000249	0.000317	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—HRAS—gallbladder cancer	0.000238	0.000303	CbGpPWpGaD
Sulindac—MAPK3—Disease—ERBB2—gallbladder cancer	0.00023	0.000292	CbGpPWpGaD
Sulindac—PTGS2—Disease—ERBB3—gallbladder cancer	0.000218	0.000277	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—NRAS—gallbladder cancer	0.000208	0.000264	CbGpPWpGaD
Sulindac—MAPK3—Immune System—NRAS—gallbladder cancer	0.00019	0.000241	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—EGFR—gallbladder cancer	0.000189	0.00024	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—KRAS—gallbladder cancer	0.000179	0.000227	CbGpPWpGaD
Sulindac—MAPK3—Disease—NRAS—gallbladder cancer	0.000175	0.000222	CbGpPWpGaD
Sulindac—ALB—Hemostasis—NRAS—gallbladder cancer	0.000174	0.000221	CbGpPWpGaD
Sulindac—MAPK3—Immune System—EGFR—gallbladder cancer	0.000173	0.000219	CbGpPWpGaD
Sulindac—MAPK3—Immune System—KRAS—gallbladder cancer	0.000163	0.000207	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—ERBB2—gallbladder cancer	0.000161	0.000205	CbGpPWpGaD
Sulindac—MAPK3—Disease—EGFR—gallbladder cancer	0.00016	0.000203	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—HRAS—gallbladder cancer	0.000152	0.000193	CbGpPWpGaD
Sulindac—MAPK3—Disease—KRAS—gallbladder cancer	0.000151	0.000191	CbGpPWpGaD
Sulindac—ALB—Hemostasis—KRAS—gallbladder cancer	0.00015	0.00019	CbGpPWpGaD
Sulindac—MAPK3—Immune System—HRAS—gallbladder cancer	0.000139	0.000176	CbGpPWpGaD
Sulindac—PTGS2—Disease—ERBB2—gallbladder cancer	0.000137	0.000174	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TP53—gallbladder cancer	0.000133	0.000169	CbGpPWpGaD
Sulindac—MAPK3—Disease—HRAS—gallbladder cancer	0.000128	0.000163	CbGpPWpGaD
Sulindac—ALB—Hemostasis—HRAS—gallbladder cancer	0.000127	0.000162	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NRAS—gallbladder cancer	0.000123	0.000156	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—EGFR—gallbladder cancer	0.000112	0.000142	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—KRAS—gallbladder cancer	0.000106	0.000134	CbGpPWpGaD
Sulindac—PTGS2—Disease—NRAS—gallbladder cancer	0.000104	0.000132	CbGpPWpGaD
Sulindac—PTGS2—Disease—EGFR—gallbladder cancer	9.49e-05	0.000121	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TP53—gallbladder cancer	9.38e-05	0.000119	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—HRAS—gallbladder cancer	8.97e-05	0.000114	CbGpPWpGaD
Sulindac—PTGS2—Disease—KRAS—gallbladder cancer	8.96e-05	0.000114	CbGpPWpGaD
Sulindac—PTGS2—Disease—HRAS—gallbladder cancer	7.62e-05	9.68e-05	CbGpPWpGaD
